Skip to main content
NVO
NYSE Life Sciences

Novo Nordisk Inks $2.6B Deal for Hengrui's Oral Obesity Drug

Tom Rudovsky · Reported by Seeking Alpha
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$38.722
Mkt Cap
$170.47B
52W Low
$35.12
52W High
$64.16
52W Position info
10% above low
Off High info
40% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

NVO is trading near its 52-week low of $35.12 (10% above the low).

Summary

Novo Nordisk is paying $300M upfront and up to $2.6B total for global rights (ex-China) to Hengrui's HRS-1596, a phase 1-ready oral GLP-1/GIP dual agonist for obesity and diabetes. This is a significant pipeline addition in the oral obesity space, where Novo already has a strong oral semaglutide franchise. The deal follows recent partnerships with Orbis Medicine ($1.4B) and Nanexa ($1.3B), showing an aggressive external innovation strategy. The transaction is expected to close in Q4 2026, pending antitrust clearance. Watch for phase 1 data readouts and any competitive response from Eli Lilly's orforglipron.

At the time of this announcement, NVO was trading at $38.72 on NYSE in the Life Sciences sector, with a market capitalization of approximately $170.5B. The 52-week trading range was $35.12 to $64.16. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Seeking Alpha.


Price Chart

Share this article

Copied!

NVO - Latest Insights

NVO
Nov 04, 2026, 8:35 AM EST
Source: Benzinga
Importance Score:
8
Price at Filing: $42.91
Real-time Price: $38.73 info
Change: -$4.18 (-10%) info
Market Cap: $176.163B info
NVO
Nov 04, 2026, 7:47 AM EST
Filing Type: 6-K
Importance Score:
9
Price at Filing: $42.90
Real-time Price: $38.73 info
Change: -$4.17 (-10%) info
Market Cap: $176.163B info
NVO
Nov 04, 2026, 4:00 AM EST
Source: Seeking Alpha
Importance Score:
9
Price at Filing: $41.96
Real-time Price: $38.73 info
Change: -$3.23 (-8%) info
Market Cap: $176.163B info
NVO
Oct 27, 2026, 3:10 AM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $39.16
Real-time Price: $38.73 info
Change: -$0.430 (-1%) info
Market Cap: $176.163B info
NVO
Oct 02, 2026, 5:53 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $36.88
Real-time Price: $38.73 info
Change: +$1.85 (+5%) info
Market Cap: $176.163B info